Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bromination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114437169B reveals a green, solvent-free ball milling method for synthesizing high-purity drospirenone intermediates, offering significant cost and supply chain advantages.
Patent CN102659623A details a green photo-bromination route for Trifloxystrobin intermediates, offering high purity and reduced waste for scalable agrochemical manufacturing.
Novel patent CN115433123B offers safer loratadine intermediate synthesis. Eliminate hazardous reagents, ensure high purity, and optimize supply chain reliability for global pharmaceutical partners.
Novel dibromohydantoin bromination method for methyl 4-bromomethylbenzoate derivatives offers high yield, reduced reaction time, and cost-effective pharma intermediate manufacturing.
Novel bromination process for 6-bromo-2-chloro-8-cyclopentyl-5-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one ensures high yield and low impurities for reliable supply chain.
Patent CN105263913B details a safer thio-1,2,4-triazole synthesis route offering high purity and cost reduction in API manufacturing for global supply chains.
Novel bromide salt method reduces toxicity and cost. Reliable supply chain for high-purity intermediates. Scalable industrial process.
Advanced synthesis of 5 alpha-pregnane-3 beta, 17 alpha-dihydroxyl-20-ketone via novel non-hydrogen debromination. Reliable supplier for Ganaxolone quality control intermediates.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Discover the clean production method for 2-fluoro-4-nitrobenzonitrile via patent CN103694137A, offering reduced waste and energy-efficient manufacturing for kinase inhibitors.
Patent CN113444004A details a cost-effective synthesis of 3,5-dibromo-o-aminobenzaldehyde from nitro waste, offering high-purity Ambroxol intermediates.
Patent CN106242941B reveals high-yield bromination method ensuring supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN118652170A enables high-yield synthesis of Dapagliflozin intermediates with reduced waste and cost for global supply chains.
Patent CN116102607B reveals a low-cost lithium-catalyzed bromination route for 25-hydroxydehydrocholesterol, offering significant supply chain and cost advantages for vitamin D3 manufacturers.
Patent CN116102607B reveals a low-cost lithium-catalyzed bromination route for 25-hydroxydehydrocholesterol, offering significant supply chain advantages for vitamin D3 producers.
Patent CN112979448A reveals a green synthesis route for SGLT-2 inhibitor intermediates with >99% purity and recyclable reagents.
Patent CN102050775A details a novel method for synthesizing and isolating a critical succinimide-based impurity of Anastrozole, ensuring robust quality control and supply chain reliability for API manufacturers.
Novel NBS method for 3-bromo-N-aryl propionamide. Green synthesis, cost reduction, reliable supply chain for pharma intermediates.
Patent CN117510296A reveals a green redox bromination method for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN102503751B reveals a water-based catalytic bromination method. Discover cost-effective, scalable manufacturing for high-purity pharmaceutical intermediates.